溃疡性结肠炎患者中抗整合素αvβ6自身抗体的鉴定
该研究通过酶联免疫吸附试验检测溃疡性结肠炎患者和对照者血清中针对23种重组整合素蛋白的抗体,发现92.0%的患者存在抗整合素αvβ6 IgG抗体,而对照组仅5.2%,诊断敏感性92.0%、特异性94.8%。抗体滴度与疾病活动度一致,且患者IgG可阻断整合素αvβ6与纤连蛋白结合并抑制细胞黏附。
要点
- 溃疡性结肠炎患者中抗整合素αvβ6抗体阳性率高达92.0%,对照组仅5.2%。
- 该抗体诊断溃疡性结肠炎的敏感性为92.0%,特异性为94.8%。
- 抗体滴度与疾病活动度一致,IgG1为主要亚类,并可阻断整合素αvβ6功能。
核心结论
- 绝大多数溃疡性结肠炎患者存在抗整合素αvβ6自身抗体,可能作为高敏感性和特异性的诊断生物标志物。
研究设计与样本
- 使用23种重组整合素蛋白对溃疡性结肠炎患者和对照者血清进行酶联免疫吸附试验,并采用免疫荧光和免疫共沉淀检查结肠组织整合素表达和IgG结合,通过固相结合和细胞黏附试验检测自身抗体的阻断活性。
主要发现
- 在训练和验证组中,103/112(92.0%)的溃疡性结肠炎患者和仅8/155(5.2%)的对照者具有抗整合素αvβ6抗体(P < .001)。
- 抗整合素αvβ6抗体滴度与溃疡性结肠炎疾病活动度一致,IgG1为主要亚类。
- 患者IgG结合于结肠上皮细胞表达的整合素αvβ6,并通过RGD三肽基序阻断整合素αvβ6与纤连蛋白结合,抑制细胞黏附。
关键数值与推荐
- 抗整合素αvβ6抗体诊断溃疡性结肠炎的敏感性为92.0%,特异性为94.8%。
临床怎么用
- 抗整合素αvβ6抗体有望作为溃疡性结肠炎的辅助诊断标志物,尤其在高敏感性和特异性需求场景下。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Ulcerative colitis is the most frequent type of inflammatory bowel disease and is characterized by colonic epithelial cell damage. Although involvement of autoimmunity has been suggested in ulcerative colitis, specific autoantigens/antibodies have yet to be elucidated. METHODS: Using 23 recombinant integrin proteins, we performed enzyme-linked immunosorbent assays on sera from patients with ulcerative colitis and controls. Integrin expression and IgG binding in the colon tissues of patients with ulcerative colitis and controls were examined using immunofluorescence and coimmunoprecipitation, respectively. The blocking activity of autoantibodies was examined using solid-phase binding and cell adhesion assays. RESULTS: Screening revealed that patients with ulcerative colitis had IgG antibodies against integrin αvβ6. In the training and validation groups, 103 of 112 (92.0%) patients with ulcerative colitis and only 8 of 155 (5.2%) controls had anti-integrin αvβ6 antibodies (P < .001), resulting in a sensitivity of 92.0% and a specificity of 94.8% for diagnosing ulcerative colitis. Anti-integrin αvβ6 antibody titers coincided with ulcerative colitis disease activity, and IgG1 was the major subclass. Patient IgG bound to the integrin αvβ6 expressed on colonic epithelial cells. Moreover, IgG of patients with ulcerative colitis blocked integrin αvβ6-fibronectin binding through an RGD (Arg-Gly-Asp) tripeptide motif and inhibited cell adhesion. CONCLUSIONS: A significant majority of patients with ulcerative colitis had autoantibodies against integrin αvβ6, which may serve as a potential diagnostic biomarker with high sensitivity and specificity.
引用
- Kuwada T, Shiokawa M, Kodama Y, et al. Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis. Gastroenterology. 2021. PMID: 33582126. doi:10.1053/j.gastro.2021.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。